Bio-Techne Cp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 126,150 | 76,086 | 104,476 | 107,735 | 110,948 |
| Depreciation Amortization | 64,463 | 60,036 | 42,764 | 37,226 | 19,175 |
| Income taxes - deferred | -46,716 | -3,433 | -2,624 | 1,304 | -2,853 |
| Accounts receivable | -2,700 | -19,686 | -22,981 | -11,747 | 1,145 |
| Accounts payable and accrued liabilities | 5,026 | 5,695 | 8,924 | 2,154 | 1,368 |
| Other Working Capital | 1,896 | -15,451 | -15,041 | -11,367 | -1,841 |
| Other Operating Activity | 22,248 | 40,474 | 28,639 | 14,054 | 8,820 |
| Operating Cash Flow | $170,367 | $143,721 | $144,157 | $139,359 | $136,762 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,819 | 3,010 | 776 | 13,466 | 182,664 |
| PPE Investments | -20,934 | -15,179 | -16,898 | -19,905 | -13,821 |
| Net Acquisitions | -67,851 | -253,785 | -91,423 | -420,102 | -109,180 |
| Purchase Of Investment | 21,574 | -40,000 | N/A | N/A | -10,000 |
| Other Investing Activity | 680 | 0 | -25 | 49 | 25 |
| Investing Cash Flow | $-38,712 | $-305,954 | $-107,570 | $-426,492 | $49,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 55,000 | 368,500 | 77,000 | 163,000 | 0 |
| Common Stock Issued | 19,170 | 5,257 | 5,458 | 9,731 | 8,326 |
| Dividend Paid | -47,973 | -47,325 | -47,607 | -47,107 | -45,394 |
| Other Financing Activity | -125,385 | -137,319 | -58,221 | -94,349 | 262 |
| Financing Cash Flow | $-99,188 | $189,113 | $-23,370 | $31,275 | $-36,806 |
| Exchange Rate Effect | -2,089 | 495 | -3,512 | -8,178 | 5,138 |
| Beginning Cash Position | 91,612 | 64,237 | 54,532 | 318,568 | 163,786 |
| End Cash Position | 121,990 | 91,612 | 64,237 | 54,532 | 318,568 |
| Net Cash Flow | $30,378 | $27,375 | $9,705 | $-264,036 | $154,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | 170,367 | 143,721 | 144,157 | 139,359 | 136,762 |
| Capital Expenditure | -20,934 | -15,179 | -16,898 | -19,905 | -13,821 |
| Free Cash Flow | 149,433 | 128,542 | 127,259 | 119,454 | 122,941 |